ADRENAL INSUFFICIENCY IN PAKISTANI HIV INFECTED PATIENTS
AbstractBackground: Adrenal insufficiency (AI) is the most common endocrine complication among patients with AIDS/HIV infection and there are number of causes of AI in HIV patients. Human immunodeficiency virus directly as well as indirectly destroys adrenal glands. The estimates of its prevalence and severity vary. AI is the most life threatening but readily correctable endocrine complication that occurs in persons with HIV infection. This study was carried out to determine the frequency of Adrenal Insufficiency in HIV patients and their clinical features as proper diagnosis and timely treatment have been shown to improve quality of life and long-term mortality in AIDS patients. Methods: It was a cross sectional survey conducted at HIV clinic and Jinnah Allama Iqbal Institute of Diabetes and Endocrinology, Jinnah Hospital Lahore. Sixty-four HIV positive patients, both male and female, aged above 15 years were included in the study. HIV patients who had recently taken steroids, ketoconazole or rifampicin, determined on history, were excluded from the study. The data was collected on a structured proforma and analysis was performed in SPSS-21.0. Frequency and percentages for adrenal insufficiency and its characteristics were calculated. Chi-square test was used with p<0.05 as statistically significant. Results: In this study, 9 (14.06%) HIV patients were diagnosed with adrenal insufficiency, male to female ratio was 3.5:1 and AI was found statistically significantly associated with fatigue (p<0.008) and weight loss (p<0.001). Conclusion: Adrenal insufficiency was high among the patients with HIV, it was not gender specific but it was found to be associated with fatigue and weight loss.Keywords: Adrenal insufficiency; HIV, Clinical features; Endocrinopathies
McKinney RE Jr, Robertson JW. Effect of human immunodeficiency virus infection on the growth of young children. Duke pediatric AIDS clinical trials unit. J Pediatr 1993;123(4):579–82.
Polsky B, Kotler D, Steinhart C. HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STDS 2001;15(8):411–23.
Schouten J, Wit FW, Stolte IG, Kootstra N, van der Valk M, Geerlings SG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study. Clin Infect Dis 2014;59(12):1787–97.
Kalra S, Sleim H, Kotwal N. Human immunodeficiency virus and the endocrine system. Indian J Endocrinol Metab 2011;15(4):231–3.
Bornstein SR. Predisposing Factors for Adrenal Insufficiency. N Engl J Med 2009;360(22):2328–39.
Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet 2016;383(9935):2152–67.
Sinha U, Sengupta N, Mukhopadhyay P, Roy KS. Human immunodeficiency virus endocrinopathy. Indian J Endocrinol Metab 2011;15(4):251–60.
Meya DB, Katabira E, Otim M, Ronald A, Colebuders R, Niama D, et al. Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. Afr Health Sci 2007;7(2):101–7.
Grinspoon S, Corcoran C, Stanley T, Rabe J, Wilkie S. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab 2001;86(9):4120–6.
Johnson SR, Marion AA, Vrchoticky T, Emmanuel PJ, Luian-Zibermann J. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr 2006;148(3):386–8.
Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR. Adrenal Crisis: Still a Deadly Event in the 21st Century. Am J Med 2016;129(3):339.
Hyle EP, Wood BR, Backman ES, Noubary F, Hwang J, Lu Z, et al. High frequency of hypothalamic-pituitary-adrenal axis dysfunction after local corticosteroid injection in HIV-infected patients on protease inhibitor therapy. J Acquir Immune Defic Syndr 2013;63(5):602–8.
Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014;275(2):104–15.
Piedrola G, Casado JL, Lopez E, Moreno A, Perez-Elias MJ, Gracia-Robles R. Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clin Endocrinol (Oxf) 1996;45(1):97–101.
Bensing S, Hulting AL, Husebye ES, Kampe O, Lovas K. Management of Endocrine Diseases: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review. Eur J Endocrinol 2016;175(3):107–16.
Wolff FH, Nhuch C, Cadore LP, Glitz CL, Lhullier F, Furlanetto TW. Low-dose adrenocorticotropin test in patients with the acquired immunodeficiency syndrome. Braz J Infect Dis 2001;5(2):53–9.
González-González JG1, de la Garza-Hernández NE, Garza-Morán RA, Rivera-Morales IM, Montes-Villarreal J, Valenzuela-Rendón J, et al. Prevalence of abnormal adrenocortical function in human immunodeficiency virus infection by low-dose cosyntropin test. Int J STD AIDS 2001;12(12):804–10.
Odeniyi IA, Fasanmade OA, Ajala MO, Ohwovoriole AE. Adrenocortical Function in Nigerians With Human Immunodeficiency Virus Infection. Ghana Med J 2013;47(4):171–7.
Huang YW, Chang CC, Sun HY, Chen MY, Hung CC, Chang SC. Primary adrenal insufficiency in patients with acquired immunodeficiency syndrome: report of four cases. J Microbiol Immunol Infect 2004;37(4):250–3.
Madi DR, Khanpure S, Ramapuran J, Achappa B, Rao S. Adrenal insufficiency in patients with acquired immunodeficiency syndrome-an underestimated problem. Retrovirology 2012;9(Suppl 1):143.
Odeniyi IA, Fasanmade OA, Ajala MO, Ohwovoriole AE. CD4 count as a predictor of adrenocortical insufficiency in persons with human immunodeficiency virus infection: How useful? Indian J Endocrinol Metab 2013;17(6):1012–7.
Ekpebegh CO, Ogbera AO, Mbenza BL, Blanco-Blanco E, Awotedu A, Oluboyo P. Basal cortisol levels and correlates of hypoadrenalism in patients with human immunodeficiency virus infection. Med Princ Pract 2011;20(6):525–9.
Soldatos G, Sztal-Mazer S, Woolley I, Stockigt J. Exogenous glucocorticoid excess as a result of ritonavir-fluticasone interaction. Intern Med J 2005;35(1):67–8.
Sobngwi E, Lubin V, Ury P, Timsit FJ, Gautier JF, Vexiau P. Adrenal insufficiency and diabetes mellitus secondary to the use of topical corticosteroids for cosmetic purpose. Ann Endocrinol (Paris) 2003;64(3):202–4.
Unachukwu CN, Uchenna DI, Young EE. Endocrine and metabolic disorders associated with human immune deficiency virus infection. West Afr J Med 2009;28(1):3–9.